Antiretroviral therapy coverage for PMTCT in Ethiopia

Ethiopia: Antiretroviral therapy coverage for PMTCT was 92.0% in 2024. ◆ Volatile

Latest (2024)
92.0%
Change on year
up 1.1%
World rank
22nd
of 84 countries
All-time high
99.0%
in 2020
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Antiretroviral therapy coverage for PMTCT in Ethiopia, 2000–2024

0204060801002000201220242000: 0 % of pregnant women living with HIV2001: 0 % of pregnant women living with HIV2002: 0 % of pregnant women living with HIV2003: 1 % of pregnant women living with HIV2004: 1 % of pregnant women living with HIV2005: 1 % of pregnant women living with HIV2006: 10 % of pregnant women living with HIV2007: 12 % of pregnant women living with HIV2008: 28 % of pregnant women living with HIV2009: 29 % of pregnant women living with HIV2010: 27 % of pregnant women living with HIV2011: 41 % of pregnant women living with HIV2012: 66 % of pregnant women living with HIV2013: 77 % of pregnant women living with HIV2014: 79 % of pregnant women living with HIV2015: 87 % of pregnant women living with HIV2016: 79 % of pregnant women living with HIV2017: 75 % of pregnant women living with HIV2018: 88 % of pregnant women living with HIV2019: 89 % of pregnant women living with HIV2020: 99 % of pregnant women living with HIV2021: 84 % of pregnant women living with HIV2022: 86 % of pregnant women living with HIV2023: 91 % of pregnant women living with HIV2024: 92 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

The most recent figure for antiretroviral therapy coverage for pmtct in Ethiopia is 92.0%, measured in 2024.

The figure is up 1.1% on the previous year and up 16.5% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Ethiopia peaked at 99.0% in 2020 and was at its lowest, 0.0%, in 2000.

That places Ethiopia 22nd out of 84 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage for PMTCT in Ethiopia, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Ethiopia, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 1.0%
2004 1.0% +0.0%
2005 1.0% +0.0%
2006 10.0% +900.0%
2007 12.0% +20.0%
2008 28.0% +133.3%
2009 29.0% +3.6%
2010 27.0% -6.9%
2011 41.0% +51.9%
2012 66.0% +61.0%
2013 77.0% +16.7%
2014 79.0% +2.6%
2015 87.0% +10.1%
2016 79.0% -9.2%
2017 75.0% -5.1%
2018 88.0% +17.3%
2019 89.0% +1.1%
2020 99.0% +11.2%
2021 84.0% -15.2%
2022 86.0% +2.4%
2023 91.0% +5.8%
2024 92.0% +1.1%

Ethiopia compared with similar countries

  • Ethiopia's 92.0% is above the median for low income countries, which is 73.0%, 1.3× the median. (22 countries reporting)
  • Ethiopia's 92.0% is above the median for Sub-Saharan Africa, which is 82.0%, 1.1× the median. (41 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage for PMTCT in Ethiopia changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2006 +900.0% 1.0% 10.0%
2008 +133.3% 12.0% 28.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 8.2% 0.0% 29.0% 10
2010s 70.8% 27.0% 89.0% 10
2020s 90.4% 84.0% 99.0% 5

Countries ranked near Ethiopia

  1. 20 Sierra Leone 93.0% compare
  2. 20 Zimbabwe 93.0% compare
  3. 22 Canada 92.0% compare
  4. 22 Tajikistan 92.0% compare
  5. 25 Peru 91.0% compare

See the full ranking of 99 places →

More health data for Ethiopia

All data for Ethiopia →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Ethiopia?
Antiretroviral therapy coverage for pmtct in Ethiopia was 92.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Ethiopia?
The highest recorded value was 99.0% in 2020.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Ethiopia?
The lowest recorded value was 0.0% in 2000.
How does Ethiopia rank for antiretroviral therapy coverage for pmtct?
Ethiopia ranks 22nd out of 84 countries with data for 2024.
Is antiretroviral therapy coverage for pmtct rising or falling in Ethiopia?
Over the last ten years it is up 16.5%. The long-run trend across the full record is volatile.
Where does this Ethiopia data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Ethiopia. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 18 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/ethiopia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/ethiopia/">Antiretroviral therapy coverage for PMTCT in Ethiopia</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).